United States · Bill · HR
H.R. 1060 (105th)
Pharmacy Compounding Act
Introduced
13 March 1997
Last action
—
Status
Referred to the Subcommittee on Health and Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Pharmacy Compounding Act - Amends the Federal Food, Drug, and Cosmetic Act to make specified provisions of that Act inapplicable to a drug or device that is compounded by a licensed pharmacist, licensed physician, or other licensed practitioner authorized by State law to prescribe drugs or devices. Declares null and void a proposed rule concerning exceptions to good manufacturing practices for makers of positron emission tomography drug products and a guideline on the manufacture of such products. Prohibits another proposed regulation or guideline on those matters.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 March 1997
Introduced in House (PDF)
Introduced in House · EN · 13 March 1997
Introduced in House
summary · EN · 13 March 1997
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/105th-congress/house-bill/1060
- Open data entity: https://api.congress.gov/v3/bill/105/hr/1060